{"id":5082,"date":"2022-06-10T12:31:11","date_gmt":"2022-06-10T16:31:11","guid":{"rendered":"https:\/\/www.wmfc.ca\/?p=5082"},"modified":"2022-06-10T12:31:11","modified_gmt":"2022-06-10T16:31:11","slug":"resumes-de-lasco","status":"publish","type":"post","link":"https:\/\/www.wmfc.ca\/fr\/2022\/06\/10\/abstracts-from-asco\/","title":{"rendered":"R\u00e9sum\u00e9s de l'ASCO"},"content":{"rendered":"<p>For those interested in keeping up with the latest research, abstracts from the most recent American Society of Clinical Oncology (ASCO) Annual Meeting have been published.\u00a0 <a href=\"https:\/\/meetings.asco.org\/abstracts-presentations\/search?q=Macroglobulinemia%202022\" target=\"_blank\" rel=\"noopener\">Here&#8217;s a link<\/a> to a search of the abstracts that mention WM.\u00a0 There are eight of them.\u00a0 (One of them is a video of Jorge Castillo, which, it appears, we cannot view without membership or registration fee to the ASCO meeting.)<\/p>\n<p>One abstract may be of particular interest, as it is a retrospective (after-the-fact) study comparing Bendamustine+Rituximab against Ibrutinib as first treatments for WM.\u00a0 Conclusion?\u00a0 &#8220;Both BR [Bendamustine+Rituximab] and Ibr [Ibrutinib] lead to comparable outcomes in patients with TN [Treatment Naive] WM, although deeper responses are attained with BR.\u00a0 <span style=\"text-decoration: underline;\">These findings require confirmation in prospective studies<\/span>.&#8221;\u00a0 (Your editor&#8217;s <span style=\"text-decoration: underline;\">emphasis<\/span> and [short form expansions] added.)<\/p>\n<p>Of course, your interests may be in different abstracts.\u00a0 As WMers, we are all so different when it comes to the details.<\/p>\n<p>(By the way, ASCO should not be confused with ASH, which is the American Society of <em>Hematology.\u00a0<\/em> ASH runs a larger conference for WM abstracts, in December.\u00a0 We&#8217;ll post that when it becomes available, too!)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>For those interested in keeping up with the latest research, abstracts from the most recent American Society of Clinical Oncology (ASCO) Annual Meeting have been published.\u00a0 Here&#8217;s a link to a search of the abstracts that mention WM.\u00a0 There are eight of them.\u00a0 (One of them is a video of Jorge Castillo, which, it appears, we cannot view without membership or registration fee to the ASCO meeting.) One abstract may be of particular interest, as it is a retrospective (after-the-fact) study comparing Bendamustine+Rituximab against Ibrutinib as first treatments for WM.\u00a0 Conclusion?\u00a0 &#8220;Both BR [Bendamustine+Rituximab] and Ibr [Ibrutinib] lead to comparable outcomes <a href=\"https:\/\/www.wmfc.ca\/fr\/2022\/06\/10\/abstracts-from-asco\/\"> [&#8230;]<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[20],"tags":[],"class_list":["post-5082","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts\/5082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/comments?post=5082"}],"version-history":[{"count":5,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts\/5082\/revisions"}],"predecessor-version":[{"id":5087,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts\/5082\/revisions\/5087"}],"wp:attachment":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/media?parent=5082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/categories?post=5082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/tags?post=5082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}